Tetravalent Bispecific Antibody, Preparation Method Therefor, and Use Thereof
AssigneeSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
InventorsJie Zhao, Haomin Huang, Zhenping Zhu, Yunxia Zhu
Life of this patent
Estimating the term…
Abstract
Provided are a structurally symmetrical tetravalent bispecific antibody based on a common light chain and a construction method therefor. The prepared tetravalent bispecific antibody has similar or even better biological activity and physical and chemical properties than monoclonal antibodies, and can be used for the treatment of various inflammatory diseases, cancer, and other diseases.
Claims17
1-40. (canceled)
A tetravalent bispecific antibody against PD-1/LAG-3, wherein the tetravalent bispecific antibody comprises two polypeptide chains and four common light chains, an amino acid sequence of the polypeptide chain is shown as SEQ ID NO. 143, and an amino acid sequence of the common light chain is shown as SEQ ID NO. 129.
Dependencies are inferred from the claim text.